Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

CADL Candel Therapeutics Inc

5,70

-0,45 (-7,32%)

26 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Candel Therapeutics (NASDAQ:CADL)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Candel Therapeutics Charts.

Candel Therapeutics (NASDAQ:CADL)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Candel Therapeutics Charts.

News Candel Therapeutics Inc

Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Dienstag 18 Juni 2024 (1 Woche vor) • GlobeNewswire Inc.

Candel Therapeutics to Join Russell 3000® Index
Dienstag 11 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma
Donnerstag 30 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 24 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 23 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting
Donnerstag 23 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
Mittwoch 22 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
Montag 20 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Candel Therapeutics Inc News-Artikel

Banque France 3875% 23/26

International Bank for R...

Hsbc France 0.8% until 1...

Netherlands AEX X10 Shor...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen